A new abuse-deterrent opioid--Xtampza ER.
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002214:Capsules; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004339:Drug Compounding; D004347:Drug Interactions; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010098:Oxycodone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index
D000701:Analgesics, Opioid; D002214:Capsules; D003692:Delayed-Action Preparations; D010098:Oxycodone